Cell surface glypicans are low-affinity endostatin receptors

Molecular Cell

Volumn 7, Issue 4, 2001, Pages 811-822

  Karumanchi, S Ananth ^a   Jha, Vivekanand ^a   Ramchandran, Ramani ^a   Karihaloo, Anil ^a,f   Tsiokas, Leonidas ^a,e   Chan, Barden ^a   Dhanabal, Mohanraj ^a   Hanai, Jun Ichi ^a   Venkataraman, Ganesh ^b   Shriver, Zachary ^b   Keiser, Nishla ^b   Kalluri, Raghu ^a   Zeng, Huiyan ^a   Mukhopadhyay, Debabrata ^a   Chen, Robert L ^d   Lander, Arthur D ^d   Hagihara, Kazuki ^c   Yamaguchi, Yu ^c   Sasisekharan, Ram ^b   Cantley, Lloyd ^a,f   Sukhatme, Vikas P ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALKALINE PHOSPHATASE; CARBOHYDRATE DERIVATIVE; CELL SURFACE RECEPTOR; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; GLYCOSAMINOGLYCAN; GLYPICAN; HEPARAN SULFATE; HEPARIN; HEXASACCHARIDE; SCATTER FACTOR; SYNDECAN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; MORPHOGENESIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0035021908     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00225-8     Document Type: Article

References (40)

1. Alberdi, E., Hyde, C.C., and Becerra, S.P. (1998). Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry 37, 10643-10652.
2. Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J., and Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
3. Bullock, S.L., Fletcher, J.M., Beddington, R.S., and Wilson, V.A. (1998). Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12, 1894-1906.
4. Chang, Z., Choon, A., and Friedl, A. (1999). Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. Am. J. Pathol. 155, 71-76.
5. Colorado, P.C., Torre, A., Kamphaus, G., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E.D., Herman, S., Sarkar, P.K., et al. (2000). Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60, 2520-2526.
6. Daniel, T.O., Stein, E., Cerretti, D.P., St John, P.L., Robert, B., and Abrahamson, D.R. (1996). ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int. Suppl. 57, S73-S81.
7. David, G., and Bernfield, M. (1998). The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol. 17, 461-463.
8. Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I.E., Lombardo, M., Iruela-Arispe, M.L., Simons, M., and Sukhatme, V.P. (1999a). Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res. 59, 189-197.
9. Dhanabal, M., Ramchandran, R., Waterman, M.J., Lu, H., Knebelmann, B., Segal, M., and Sukhatme, V.P. (1999b). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
10. Dhanabal, M., Volk, R., Ramchandran, R., Simons, M., and Sukhatme, V.P. (1999c). Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res. Commun. 258, 345-352.
11. Dixelius, J., Larsson, H., Sasaki, T., Holmqvist, K., Lu, L., Engstrom, A., Timpl, R., Welsh, M., and Claesson-Welsh, L. (2000). Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95, 3403-3411.
12. Feitsma, K., Hausser, H., Robenek, H., Kresse, H., and Vischer, P. (2000). Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate. J. Biol. Chem. 275, 9396-9402.
13. Flanagan, J.G., and Leder, P. (1990). The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63, 185-194.
14. Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., and Ron, D. (1999). Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274, 10816-10822.
15. Hagihara, K., Watanabe, K., Chun, J., and Yamaguchi, Y. (2000). Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells. Dev. Dyn. 219, 353-367.
16. Halfter, W., Dong, S., Schurer, B., and Cole, G.J. (1998). Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404-25412.
17. Hohenester, E., Sasaki, T., Olsen, B.R., and Timpl, R. (1998). Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J. 17, 1656-1664.
18. Keiser, N., Venkataraman, G., Shriver, Z., and Sasisekharan, R. (2001). Direct isolation and sequencing of specific protein- binding glycosaminoglycans. Nat. Med. 7, 123-128.
19. Kjelsberg, C., Sakurai, H., Spokes, K., Birchmeier, C., Drummond, I., Nigam, S., and Cantley, L.G. (1997). Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands. Am. J. Physiol. 272, F222-F228.
20. Knebelmann, B., Ananth, S., Cohen, H.T., and Sukhatme, V.P. (1998). Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res. 58, 226-231.
21. Litwack, E.D., Ivins, J.K., Kumbasar, A., Paine-Saunders, S., Stipp, C.S., and Lander, A.D. (1998). Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn. 211, 72-87.
22. Maeshima, Y., Colorado, P.C., Torre, A., Holthaus, K.A., Grunkemeyer, J.A., Ericksen, M.B., Hopfer, H., Xiao, Y., Stillman, I.E., and Kalluri, R. (2000). Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275, 21340-21348.
23. Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J.M., and Iozzo, R.V. (2000). The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095-7100.
24. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J.L., Lehmann, S., Launay, J.M., and Kellermann, O. (2000). Signal transduction through prion protein. Science 289, 1925-1928.
25. Natke, B., Venkataraman, G., Nugent, M.A., and Sasisekharan, R. (2000). Heparinase treatment of smooth muscle cells inhibit FGF-2 binding to FGFR1, but not FGF-2 mediated cellular proliferation. Angiogenesis 3, 249-257.
26. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
27. O'Reilly, M.S., Pirie-Shepherd, S., Lane, W.S., and Folkman, J. (1999). Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285, 1926-1928.
28. Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93, 11400-11406.
29. Rauchman, M.I., Nigam, S.K., Delpire, E., and Gullans, S.R. (1993). An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am. J. Physiol. 265, F416-F424.
30. Sakata, H., Stahl, S.J., Taylor, W.G., Rosenberg, J.M., Sakaguchi, K., Wingfield, P.T., and Rubin, J.S. (1997). Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J. Biol. Chem. 272, 9457-9463.
31. Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., and Timpl, R. (1999). Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248.
32. Sertie, A.L., Sossi, V., Camargo, A.A., Zatz, M., Brahe, C., and Passos-Bueno, M.R. (2000). Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum. Mol. Genet. 9, 2051-2058.
33. Solomon, K.R., Rudd, C.E., and Finberg, R.W. (1996). The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc. Natl. Acad. Sci. USA 93, 6053-6058.
34. Tumova, S., Woods, A., and Couchman, J.R. (2000). Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 32, 269-288.
35. van Der Voort, R., Keehnen, R.M., Beuling, E.A., Spaargaren, M., and Pals, S.T. (2000). Regulation of cytokine signaling by B cell antigen receptor and CD40- controlled expression of heparan sulfate proteoglycans. J. Exp. Med. 192, 1115-1124.
36. Venkataraman, G., Shriver, Z., Davis, J.C., and Sasisekharan, R. (1999). Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans. Proc. Natl. Acad. Sci. USA 96, 1892-1897.
37. Venkataraman, G., Shriver, Z., Raman, R., and Sasisekharan, R. (1999). Sequencing complex polysaccharides. Science 286, 537-542.
38. Volk, R., Schwartz, J.J., Li, J., Rosenberg, R.D., and Simons, M. (1999). The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J. Biol. Chem. 274, 24417-24424.
39. Watanabe, K., Yamada, H., and Yamaguchi, Y. (1995). K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J. Cell Biol. 130, 1207-1218.
40. Yamaguchi, N., Anand-Apte, B., Lee, M., Sasaki, T., Fukai, N., Shapiro, R., Que, I., Lowik, C., Timpl, R., and Olsen, B.R. (1999). Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18, 4414-4423.